Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-22-002703
Filing Date
2022-09-26
Accepted
2022-09-26 16:54:45
Documents
2

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13G sc13g07422pnt_09262022.htm SC 13G 275571
2 JOINT FILING AGREEMENT ex991to13g07422pnt_09262022.htm EX-99.1 8394
  Complete submission text file 0000921895-22-002703.txt   285600
Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

EIN.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957
POINT Biopharma Global Inc. (Subject) CIK: 0001811764 (see all company filings)

EIN.: 850800493 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91575 | Film No.: 221266361
SIC: 2834 Pharmaceutical Preparations